Aurobindo Income Before Tax from 2010 to 2024

AUROPHARMA   1,238  14.45  1.18%   
Aurobindo Pharma's Income Before Tax is increasing over the years with slightly volatile fluctuation. Overall, Income Before Tax is expected to go to about 46 B this year. From 2010 to 2024 Aurobindo Pharma Income Before Tax quarterly data regression line had arithmetic mean of  28,120,499,667 and significance of  0.0005. View All Fundamentals
 
Income Before Tax  
First Reported
2011-12-31
Previous Quarter
13.3 B
Current Value
12.1 B
Quarterly Volatility
5.7 B
 
Yuan Drop
 
Covid
Check Aurobindo Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Aurobindo Pharma's main balance sheet or income statement drivers, such as Depreciation And Amortization of 15.7 B, Interest Expense of 3 B or Selling General Administrative of 8.6 B, as well as many indicators such as . Aurobindo financial statements analysis is a perfect complement when working with Aurobindo Pharma Valuation or Volatility modules.
  
This module can also supplement various Aurobindo Pharma Technical models . Check out the analysis of Aurobindo Pharma Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Aurobindo Stock

Aurobindo Pharma financial ratios help investors to determine whether Aurobindo Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Aurobindo with respect to the benefits of owning Aurobindo Pharma security.